-
SICEM 2022
SICEM 2022
- Program
- Abstracts
- Participation
- Venue
-
News & Gallery
News & Gallery
Today : 2025.06.03
D--95
Scientific Program
- Plenary Lecture
- Meet the Professor
- HOT Topic
- Namgok Award Lecture
- Symposium
- Clinical Ultrasound CME & Hands-on (Korean only)
- Special Session
- Clinical Update
- Joint Symposium
- Satellite Symposium
- Breakfast/Luncheon
Breakfast/Luncheon
-
Luncheon Symposium 1
Day 2, October 28(Fri), 2022 / 12:10-13:10 / Room 1
Chairperson : Dong Jin CHUNG (Chonnam National University, Korea)
12:10-12:30
Key Updates on the Recent Guidelines - PCSK9 Inhibitors for Whom and When? (Endocrinology Perspective)
Jun Hwa HONG (Eulji University, Korea)
12:30-12:50
How to Integrate Semaglutide into Clinical Practice - Focusing on Case Sharing in UK
Adie VILJOEN (East and North Hertfordshire NHS Trust, UK)
-
Luncheon Symposium 2
Day 2, October 28(Fri), 2022 / 12:10-13:10 / Room 2
Chairperson : Yong-Wook CHO (CHA University, Korea)
12:10-12:30
How to Find Optimal Combination Therapy for Patient with Type 2 DM
Seung Jin HAN (Ajou University, Korea)
12:30-12:50
How to Treat Hypertension in the Metabolic Syndrome
Su Jin JEONG (Bucheon Sejong General Hospital, Korea)
-
Luncheon Symposium 3
Day 2, October 28(Fri), 2022 / 12:10-13:10 / Room 3
Chairperson : Sung Dae MOON (The Catholic University of Korea, Korea)
12:10-12:30
Evogliptin CVOS: A Nationwide Cohort Study
Jung Hwan PARK (Hanyang University, Korea)
12:30-12:50
How Does Empagliflozin Connect to Heart and Kidney?
Sang Yong KIM (Chosun University, Korea)
-
Breakfast Symposium 1
Day 3, October 29(Sat), 2022 / 07:30-08:30 / Room 3
Chairperson : Sung-Hoon KIM (MizMedi Hospital, Korea)
07:30-07:50
New Paradigm of Glycemic Variability: EVERGREEN Study
Yeo Ree YANG (The Catholic University of Korea, Korea)
07:50-08:10
When to Use Dulaglutide(Trulicity)?
Eun-Hee CHO (Kangwon National University, Korea)
-
Breakfast Symposium 2
Day 3, October 29(Sat), 2022 / 07:30-08:30 / Room 5
Chairperson : Hyeong-Kyu PARK (Soonchunhyang University, Korea)
07:30-07:50
Optimal LDL-C Targets in Patients with Diabetes Mellitus: The Lower, the Better?
Da Hea SEO (Inha University, Korea)
07:50-08:10
Strategy of Blood Pressure Intervention in the Elderly and DM Patients
Sangmo HONG (Hanyang University, Korea)
-
Luncheon Symposium 4
Day 3, October 29(Sat), 2022 / 12:00-13:10 / Room 1
Chairperson : Byung-Joon KIM (Gachon University, Korea)
12:00-12:20
Benefit of DPP4 Inhibitor in Patients with Type 2 Diabetes based on 2022 ADA Guideline
Jae-Han JEON (Kyungpook National University, Korea)
12:20-12:40
Enavogliflozin, A Novel Sodium-Glucose Co-transporter2 (SGLT-2) Inhibitor
Seung Hwan LEE (Clinical Pharmacololgy and Therapeutics, Seoul National University, Korea)
-
Luncheon Symposium 5
Day 3, October 29(Sat), 2022 / 12:00-13:10 / Room 2
Chairperson : Hyoung Woo LEE (Yeungnam University, Korea)
12:00-12:20
The Combination of DPP-4 Inhibitor Plus SGLT2 Inhibitor as Attractive Treatment Option: From Rationale to Clinical Aspects
Jee Hee YOON (Chonnam National University, Korea)
12:20-12:40
Best Strategy Based on NEW EVIDENCE for Reaching Lower LDL-C Goals
Seung-Hwan LEE (The Catholic University of Korea, Korea)
- Luncheon Symposium 1 Day 2, October 28(Fri), 2022 / 12:10-13:10 / Room 1
Chairperson : Dong Jin CHUNG (Chonnam National University, Korea)
|
|
12:10-12:30 | Key Updates on the Recent Guidelines - PCSK9 Inhibitors for Whom and When? (Endocrinology Perspective) Jun Hwa HONG (Eulji University, Korea) |
|
|
12:30-12:50 | How to Integrate Semaglutide into Clinical Practice - Focusing on Case Sharing in UK Adie VILJOEN (East and North Hertfordshire NHS Trust, UK) |
- Luncheon Symposium 2 Day 2, October 28(Fri), 2022 / 12:10-13:10 / Room 2
Chairperson : Yong-Wook CHO (CHA University, Korea)
|
|
12:10-12:30 | How to Find Optimal Combination Therapy for Patient with Type 2 DM Seung Jin HAN (Ajou University, Korea) |
|
|
12:30-12:50 | How to Treat Hypertension in the Metabolic Syndrome Su Jin JEONG (Bucheon Sejong General Hospital, Korea) |
- Luncheon Symposium 3 Day 2, October 28(Fri), 2022 / 12:10-13:10 / Room 3
Chairperson : Sung Dae MOON (The Catholic University of Korea, Korea)
|
|
12:10-12:30 | Evogliptin CVOS: A Nationwide Cohort Study Jung Hwan PARK (Hanyang University, Korea) |
|
|
12:30-12:50 | How Does Empagliflozin Connect to Heart and Kidney? Sang Yong KIM (Chosun University, Korea) |
- Breakfast Symposium 1 Day 3, October 29(Sat), 2022 / 07:30-08:30 / Room 3
Chairperson : Sung-Hoon KIM (MizMedi Hospital, Korea)
|
|
07:30-07:50 | New Paradigm of Glycemic Variability: EVERGREEN Study Yeo Ree YANG (The Catholic University of Korea, Korea) |
|
|
07:50-08:10 | When to Use Dulaglutide(Trulicity)? Eun-Hee CHO (Kangwon National University, Korea) |
- Breakfast Symposium 2 Day 3, October 29(Sat), 2022 / 07:30-08:30 / Room 5
Chairperson : Hyeong-Kyu PARK (Soonchunhyang University, Korea)
|
|
07:30-07:50 | Optimal LDL-C Targets in Patients with Diabetes Mellitus: The Lower, the Better? Da Hea SEO (Inha University, Korea) |
|
|
07:50-08:10 | Strategy of Blood Pressure Intervention in the Elderly and DM Patients Sangmo HONG (Hanyang University, Korea) |
- Luncheon Symposium 4 Day 3, October 29(Sat), 2022 / 12:00-13:10 / Room 1
Chairperson : Byung-Joon KIM (Gachon University, Korea)
|
|
12:00-12:20 | Benefit of DPP4 Inhibitor in Patients with Type 2 Diabetes based on 2022 ADA Guideline Jae-Han JEON (Kyungpook National University, Korea) |
|
|
12:20-12:40 | Enavogliflozin, A Novel Sodium-Glucose Co-transporter2 (SGLT-2) Inhibitor Seung Hwan LEE (Clinical Pharmacololgy and Therapeutics, Seoul National University, Korea) |
- Luncheon Symposium 5 Day 3, October 29(Sat), 2022 / 12:00-13:10 / Room 2
Chairperson : Hyoung Woo LEE (Yeungnam University, Korea)
|
|
12:00-12:20 | The Combination of DPP-4 Inhibitor Plus SGLT2 Inhibitor as Attractive Treatment Option: From Rationale to Clinical Aspects Jee Hee YOON (Chonnam National University, Korea) |
|
|
12:20-12:40 | Best Strategy Based on NEW EVIDENCE for Reaching Lower LDL-C Goals Seung-Hwan LEE (The Catholic University of Korea, Korea) |